Octave

01/08/2026

Starting 2026 with incredible momentum!

We're thrilled to welcome Kirk Stockwood to Octave as our new Senior Vice President, Commercial.

Kirk brings deep experience building and scaling commercial teams in specialty diagnostics, most recently leading global neurology and immunology sales at Quanterix. His background also includes leadership roles at leading companies in precision medicine, including Natera, 10x Genomics, Veritas Genetics, and Color Genomics, where he's launched transformative diagnostic solutions, scaled high-performing teams, and driven significant growth and market expansion.

As we expand access to the Octave MSDA Test and continue building our precision neurology platform, Kirk will lead our commercial strategy and help us reach more patients and providers who need better tools for managing neurodegenerative diseases.

Welcome to the team, Kirk!

Read more: https://www.businesswire.com/news/home/20260108717614/en/Octave-Bioscience-Expands-Leadership-Team-with-Appointment-of-Kirk-Stockwood-Senior-Vice-President-Commercial

12/01/2025

Today marks an important milestone for Octave and for the MS community.

We’re excited to share a new collaboration with Quest Diagnostics, unlocking nationwide access to the Octave® MSDA Test through ~7,000 Quest patient service centers and in-office phlebotomists across the U.S.

This collaboration reflects what matters most: making proactive, precise MS care easier to deliver and easier for patients to access.

For clinicians, it removes friction from ordering and access while providing objective, clinically validated insights that strengthen treatment decisions, all so patients can navigate their MS journey with less burden and more clarity and control.

Partnering with a trusted national leader like Quest Diagnostics reinforces our shared commitment to a higher standard of care for people living with MS.

👉 Read the full announcement: https://lnkd.in/gGaQJx6p

05/10/2024

Octave has been recognized as the “Best Care Management Platform” in the 8th Annual MedTech Breakthrough award program. The recognition is a testament to our success in delivering actionable insights in a precision medicine solution for MS and our vision to redefine the standard of care for neurological diseases. Learn more:https://medtechbreakthrough.com/2024-winners/

03/14/2024

MS Advocate Brittany Quiroz, A Hot MS is changing perceptions around life with disability. From hosting the podcast "All the Odds with A Hot MS" to initiating the ART4aCAUSE charity project, Quiroz is blazing a trail for others living with MS to “embrace their mess.” In honor of MS Awareness Month, she's extending her impact through music with the release of her first song, "Never Have My Soul," from her upcoming album, “8:28.” All proceeds will benefit the National MS Society

Read more about Brittany's MS journey and how it fuels her greater purpose:

For Brittany Quiroz, an MS diagnosis was an answer to years of prayer, as it helped her find her life's purpose.

03/13/2024

We want to extend our thanks to everyone who visited the Octave team, engaged in insightful conversations, and made ACTRIMS Forum 2024 exceptional!
It was a pleasure to connect with attendees and share how Octave's Multiple Sclerosis Disease Activity ( ) Test, the first-and-only multivariate biomarker blood test is delivering actionable insights for more confident management.
Octave is proud to have had seven company and partner posters featured at the event. Check out all of Octave's posters by visiting https://www.octavebio.com/actrims-2024-post-event/

02/29/2024

Don't miss Octave and our collaborators at the 2024 poster presentations:

1️⃣ Poster Session 1
🕕 Thursday, February 29, 6:00 - 7:30pm

2️⃣ Poster Session 2
🕕 Friday, March 1, 6:00 - 7:30pm

➡️ Visit us at Pod #631! Schedule your meeting with the Octave team and view the full list of posters: https://www.octavebio.com/actrims2024-pre-event/

02/23/2024

Discover how Octave's Multiple Sclerosis Disease Activity (MSDA) Test, the first-and-only multivariate biomarker blood test that provides accurate measurement of multiple sclerosis (MS) disease activity, is delivering actionable insights for more confident management in clinics around the country, at 2024, February 29 – March 2!

Learn more about the science behind our Precision Care Solution at the poster presentations:

▪️ Poster Session 1
▪️ Thursday, February 29, 6:00 - 7:30pm

▪️ Poster Session 2
▪️ Friday, March 1, 6:00 - 7:30pm

➡️ Visit us at Pod #631: https://bit.ly/4bJV4bw

02/17/2024

Octave is excited to be a part of 2024! ✈️

Join us at the ninth annual ACTRIMS event, February 29 – March 2 in West Palm Beach, Florida to learn how we are changing the paradigm of care in (MS) with our MS Solution.

➡️ Stop by Pod #631 at or schedule your meeting: https://www.octavebio.com/actrims2024-pre-event/

02/02/2024

Thrilled to announce the launch of our dedicated patient webpage! 🌐︎

Designed with patients in mind, this comprehensive webpage provides easy access to valuable information about our multiple sclerosis (MS) Precision Care Solution.

Learn more ➡️ https://www.octavebio.com/patients/

02/01/2024

Thrilled to announce the launch of our dedicated patient webpage! 🌐︎

Designed with patients in mind, this comprehensive webpage provides easy access to valuable information about our multiple sclerosis (MS) Precision Care Solution.

Learn more ➡️ https://www.octavebio.com/patients/

01/27/2024

Every person living with multiple sclerosis (MS) is unique and there are limited tools available that measure disease activity over time.

Octave’s Multiple Sclerosis Disease Activity (MSDA) Test enables clinicians to measure this activity through a simple blood test that gives a numeric score to measure and track disease activity over time.

Learn more about Octave’s MSDA test and the Precision Care Solution: https://www.octavebio.com/octave-msda-informational-video/

01/23/2024

Join Olink Proteomics and Octave at PMWC - Precision Medicine World Conference to hear Ferhan Qureshi, VP of Biomarker Product Development at Octave present "Bridging Proteomics to the Clinic – A Multivariate Blood Test for Disease Activity in Multiple Sclerosis" at 9:45 a.m. PT on Thursday, Jan. 25 in the Showcase Track S2.

Learn more ➡️ https://bit.ly/480X8Jr